Creades AB Logo

Creades AB

0QI9.L

(0.2)
Stock Price

69,65 SEK

2.54% ROA

6.33% ROE

45.37x PER

Market Cap.

9.563.454.406,00 SEK

0% DER

1.53% Yield

308.29% NPM

Creades AB Stock Analysis

Creades AB Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Creades AB Fundamental Stock Analysis
# Analysis Rating
1 Dividend

The company has consistently provided dividends over the past three years, indicating a reliable source of income for investors.

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

11 ROE

Unidentified ROE

Creades AB Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Creades AB Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Creades AB Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Creades AB Revenue
Year Revenue Growth
2012 108.000.000
2013 1.067.000.000 89.88%
2014 563.000.000 -89.52%
2015 1.155.000.000 51.26%
2016 1.211.000.000 4.62%
2017 1.266.000.000 4.34%
2018 1.281.000.000 1.17%
2019 1.130.000.000 -13.36%
2020 4.015.000.000 71.86%
2021 4.474.000.000 10.26%
2022 -4.203.000.000 206.45%
2023 -3.580.000.000 -17.4%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Creades AB Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Creades AB General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 12.000.000
2013 129.000.000 90.7%
2014 42.000.000 -207.14%
2015 52.000.000 19.23%
2016 30.000.000 -73.33%
2017 24.000.000 -25%
2018 66.000.000 63.64%
2019 6.000.000 -1000%
2020 7.000.000 14.29%
2021 7.000.000 0%
2022 12.000.000 41.67%
2023 224.000.000 94.64%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Creades AB EBITDA
Year EBITDA Growth
2012 -63.000.000
2013 835.000.000 107.54%
2014 441.000.000 -89.34%
2015 533.000.000 17.26%
2016 327.000.000 -63%
2017 265.000.000 -23.4%
2018 534.000.000 50.37%
2019 1.078.000.000 50.46%
2020 3.658.000.000 70.53%
2021 4.223.000.000 13.38%
2022 -3.961.000.000 206.61%
2023 -3.352.000.000 -18.17%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Creades AB Gross Profit
Year Gross Profit Growth
2012 -47.000.000
2013 965.000.000 104.87%
2014 482.000.000 -100.21%
2015 584.000.000 17.47%
2016 498.000.000 -17.27%
2017 484.000.000 -2.89%
2018 735.000.000 34.15%
2019 1.130.000.000 34.96%
2020 4.015.000.000 71.86%
2021 4.474.000.000 10.26%
2022 -4.203.000.000 206.45%
2023 -3.580.000.000 -17.4%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Creades AB Net Profit
Year Net Profit Growth
2012 -125.000.000
2013 814.000.000 115.36%
2014 420.000.000 -93.81%
2015 548.000.000 23.36%
2016 307.000.000 -78.5%
2017 244.000.000 -25.82%
2018 530.000.000 53.96%
2019 1.086.000.000 51.2%
2020 3.647.000.000 70.22%
2021 4.193.000.000 13.02%
2022 -3.948.000.000 206.21%
2023 -3.308.000.000 -19.35%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Creades AB Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 0
2013 5 100%
2014 3 -100%
2015 4 50%
2016 2 -100%
2017 2 -100%
2018 4 75%
2019 9 50%
2020 29 72.41%
2021 32 6.45%
2022 -29 206.9%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Creades AB Free Cashflow
Year Free Cashflow Growth
2012 171.000.000
2013 -263.000.000 165.02%
2014 -23.000.000 -1043.48%
2015 57.000.000 140.35%
2016 -96.000.000 159.38%
2017 32.000.000 400%
2018 29.000.000 -10.34%
2019 -28.000.000 203.57%
2020 16.000.000 275%
2021 89.000.000 82.02%
2022 25.000.000 -256%
2023 97.000.000 74.23%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Creades AB Operating Cashflow
Year Operating Cashflow Growth
2012 171.000.000
2013 -263.000.000 165.02%
2014 -23.000.000 -1043.48%
2015 59.000.000 138.98%
2016 -93.000.000 163.44%
2017 39.000.000 338.46%
2018 35.000.000 -11.43%
2019 -27.000.000 229.63%
2020 16.000.000 268.75%
2021 89.000.000 82.02%
2022 25.000.000 -256%
2023 97.000.000 74.23%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Creades AB Capital Expenditure
Year Capital Expenditure Growth
2012 0
2013 0 0%
2014 0 0%
2015 2.000.000 100%
2016 3.000.000 33.33%
2017 7.000.000 57.14%
2018 6.000.000 -16.67%
2019 1.000.000 -500%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Creades AB Equity
Year Equity Growth
2012 3.583.000.000
2013 2.786.000.000 -28.61%
2014 2.832.000.000 1.62%
2015 3.151.000.000 10.12%
2016 3.319.000.000 5.06%
2017 3.399.000.000 2.35%
2018 3.699.000.000 8.11%
2019 4.610.000.000 19.76%
2020 7.951.000.000 42.02%
2021 12.945.000.000 38.58%
2022 8.807.000.000 -46.99%
2023 7.986.000.000 -10.28%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Creades AB Assets
Year Assets Growth
2012 3.649.000.000
2013 3.122.000.000 -16.88%
2014 3.118.000.000 -0.13%
2015 3.348.000.000 6.87%
2016 3.519.000.000 4.86%
2017 3.580.000.000 1.7%
2018 3.744.000.000 4.38%
2019 4.656.000.000 19.59%
2020 8.341.000.000 44.18%
2021 13.520.000.000 38.31%
2022 9.052.000.000 -49.36%
2023 8.114.000.000 -11.56%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Creades AB Liabilities
Year Liabilities Growth
2012 62.000.000
2013 158.000.000 60.76%
2014 113.000.000 -39.82%
2015 197.000.000 42.64%
2016 200.000.000 1.5%
2017 181.000.000 -10.5%
2018 45.000.000 -302.22%
2019 39.000.000 -15.38%
2020 390.000.000 90%
2021 575.000.000 32.17%
2022 245.000.000 -134.69%
2023 127.000.000 -92.91%

Creades AB Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.05
Net Income per Share
1.52
Price to Earning Ratio
45.37x
Price To Sales Ratio
66.88x
POCF Ratio
59.54
PFCF Ratio
60.91
Price to Book Ratio
1.17
EV to Sales
63.92
EV Over EBITDA
53.77
EV to Operating CashFlow
58.22
EV to FreeCashFlow
58.22
Earnings Yield
0.02
FreeCashFlow Yield
0.02
Market Cap
9,56 Bil.
Enterprise Value
9,14 Bil.
Graham Number
44.81
Graham NetNet
2.18

Income Statement Metrics

Net Income per Share
1.52
Income Quality
0.76
ROE
0.02
Return On Assets
0.06
Return On Capital Employed
0.06
Net Income per EBT
1
EBT Per Ebit
1.07
Ebit per Revenue
2.88
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
5.23
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
3.1
Operating Profit Margin
2.88
Pretax Profit Margin
3.08
Net Profit Margin
3.08

Dividends

Dividend Yield
0.02
Dividend Yield %
1.53
Payout Ratio
0.92
Dividend Per Share
1.05

Operating Metrics

Operating Cashflow per Share
1.16
Free CashFlow per Share
1.16
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.02
Return on Tangible Assets
0.03
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
3,12
Book Value per Share
58,82
Tangible Book Value per Share
58.83
Shareholders Equity per Share
58.82
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-2.49
Current Ratio
3.54
Tangible Asset Value
7,99 Bil.
Net Current Asset Value
0,32 Bil.
Invested Capital
0
Working Capital
0,32 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Creades AB Dividends
Year Dividends Growth
2017 14
2020 7 -100%
2021 4 -133.33%
2022 1 -200%
2023 1 0%

Creades AB Profile

About Creades AB

Creades AB is a private equity and venture capital investment firm specializing in seed/startup, early, mid & late venture, emerging growth, middle market, growth capital and buyout investments. The firm typically invests in small and medium-sized public and private companies. It focuses on Swedish companies. The firm seeks to invest between SEK100 ($15.51 million) and SEK300 million ($46.53 million). The firm prefers to take a majority stake and seat on the board of directors of its portfolio companies. The firm uses personal and balance sheet capital for making investments. Creades AB was founded in 2011 and is based in Stockholm, Sweden.

CEO
Mr. John Hedberg
Employee
8
Address
Ingmar Bergmans gata 4
Stockholm, 10216

Creades AB Executives & BODs

Creades AB Executives & BODs
# Name Age
1 Ms. Lisa Birgerson
Administration Manager
70
2 Mr. Erik Törnberg
Member of Investment Organization
70
3 Ms. Dajana Mirborn
Investment Manager
70
4 Mr. Anders Hillerborg
Member of the Investment Organization
70
5 Mr. Daniel Albin
Member of the Investment Organization
70
6 Mr. John Hedberg
Chief Executive Officer & MD
70
7 Ms. Christina Hilmersson
Chief Financial Officer
70
8 Mr. Jonas Hagstromer
Member of Investment Organization
70

Creades AB Competitors

Medifast, Inc. Logo
Medifast, Inc.

0K05.L

(0.0)
Creades AB Logo
Creades AB

CRED-A.ST

(1.8)